INTRODUCTION
Dr Stephen J. Huot:
The clinical features, natural history, diagnosis and management of renal artery stenosis in patients with hypertension and renal insufficiency will be illustrated by discussion of a patient evaluated at the Yale Vascular Center. Dr. Leslie Scoutt, Department of Diagnostic Imaging, will discuss the utility of renal doppler ultrasound studies for diagnosing renal artery stenosis and review the findings in this patient. Dr. George Meier, Department of Surgery, will discuss surgical approachs and management of patients with complex vascular disease manifested by renal artery stenosis and renal insufficiency.
CASE PRESENTATION
The patient is a 72 year old white woman who presented in July 1995 with refractory hypertension and progressive renal insufficiency. Her clinical course is outlined in Figure 1 . She was first diagnosed with high blood pressure in 1970 which had been successfully controlled with medication until September 1994. At that time, her blood pressure became poorly controlled, requiring several changes in her medications. Her blood pressure remained elevated despite these changes. She stated that she was compliant with her medications, was not taking any over-the-counter drugs such as non-steroidal antiinflammatory agents or decongestants, and that her weight had been stable with no change in her physical activity level.
In January 1995, four months after the documented worsening of blood pressure control, the patient was admitted to her local hospital in New York with unstable angina and ruled in for a non-Q-wave myocardial infarction. Echocardiogram revealed anterior and inferior hypokinesis with an estimated ejection fraction of 38 percent. There was both tricuspid and mitral regurgitation. On the second hospital day, despite treatment with aspirin, aTo whom all correspondence should be addressed: Stephen J. Huot Prevalence. Data from autopsy series, studies of patients undergoing aortograms, and studies of patients referred for cardiac catheterization show a prevalence of RAS that ranges from 29 percent to 60 percent. None of these represent an "unselected" patient population and therefore undoubtedly overestimate the prevalence of RAS in the general population. Interestingly, the prevalence of bilateral disease among patients with renal artery stenosis is quite high as illustrated in Table 1 . The incidence of bilateral disease reported in the 5 studies presented in this table range from 27 percent to 66 percent of patients with arteriographically documented RAS [1] [2] [3] [4] [5] [6] [7] [8] . In 1984 Schreiber and colleagues reported a retrospective study which included 85 hypertensive patients with atherosclerotic RAS who had follow-up arteriograms from 6 to 84 months after their initial study [7] . Thirty seven of the 85 patients (44 percent) showed progression of the original lesion including 14 (16 percent [9] . Twenty-seven percent of the white hypertensives and 20 percent of the black hypertensives had RAS (no significant difference). Half of the patients in each group had RVH in that blood pressure control improved with revascularization. Additional studies have reported similar results. Therefore, although RAS may be slightly more prevalent in white hypertensives, it is also common in black hypertensives.
The patient we are discussing today had advanced age, history of tobacco use, and documented vascular disease. We thought it likely that she had renal artery stenosis and possibly renovascular hypertension. Given the prevalence and natural history of RAS, we also thought it possible that she had developed bilateral disease and that this was the cause of her deterioration in renal function.
Diagnosis. There are two categories of diagnostic tests available to help determine whether or not patients have RAS and RVH. These include functional studies and a variety of imaging modalities (Table 2) .
Of the functional studies, plasma renin assays vary significantly with sodium intake, volume status, cardiac output and even position. Blood pressure response to pharmacologic agents such as angiotensin-converting enzyme inhibitors is dependent on volume status and co-morbid conditions and is also not reliable [3, 10] . CRSs are commonly used at YNHH and will be discussed in greater detail. [12] .
These issues were of concern in the interpretation of our patient's study. She had severe renal insufficiency and her CRS showed a nonfunctioning right kidney. Physiologically this is equivalent to trying to identify stenosis in a patient with a solitary kidney. Utility of the test in this setting is therefore limited. Given her presentation and the presence of clinical characteristics consistent with RAS, we felt it likely that she had the disease despite a negative CRS and decided to proceed with imaging studies. Choosing the appropriate imaging study in this particular patient, however, was not straightforward because of her history of artheroembolic disease, congestive heart failure, and renal insufficiency.
There are six imaging modalities available to visualize the renal arteries (Table 2) . Each has limitations and benefits. Conventional arteriography is considered the "gold standard." Contrast induced nephropathy and atheroembolism from arterial puncture and canulation of the renal arteries pose significant risks in patients with renal insufficiency and diffuse vascular disease as was the case in our patient [3, 13, 14] . The presence of an anatomic lesion on arteriogram also does not necessarily mean the patient has renovascular hypertension or that the stenosis is the cause of renal insufficiency if present. Our initial focus therefore was to try to rule out RAS with non-invasive or with less invasive imaging procedures rather than proceed directly with a renal arteriogram.
With intravenous digital subtraction angiography, computer enhancement provides an improved image of the renal arteries after injection of contrast. While avoiding manipulation of the aorta and renal arteries, the results are technically limited by obesity, movement, and presence of bowel gas and it still requires the administration of contrast dye. Intra-arterial digital subtraction angiography provides higher quality images but offers minimal advantage over conventional arteriography in that it requires intraarterial injection of contrast, though often with a lower volume of dye [13, 15] .
Magnetic resonance arteriography is an evolving technology that holds great promise as a non-invasive arterial imaging technique [16] . Presently, respiratory artifact, peristalsis, tortuous vessels, calcification of ateromatous lesions, and turbulent flow are limiting factors. The procedure is still experimental at many institutions and requires validation with conventional arteriography. In addition, current magnetic resonance arteriography does not provide high resolution imaging of the celiac axis and its branches which are frequently used in revascularization procedures for patients with complex vascular disease. This technique is also not sensitive for identifying stenoses in smaller accessory vesels or in branch vessels.
Carbon dioxide arteriography has been developed as a non-contrast imaging alternative to conventional arteriography [17] . Advantages are that CO2 is nonallergenic, is not nephrotoxic and is considerably less expensive than contrast dye. Presently, the technique is limited in that it requires intra-arterial injection, has considerable variability in quality due to bowel gas and peristalsis, and there is difficulty with the CO2 injection systems. It is an alternative for patients with known contrast dye allergy but is not suitable for routine imaging of patients with suspected renal artery stenosis.
Doppler ultrasound is the imaging modality we chose to pursue initially. Although current Doppler ultrasound technology has limitations, the procedure is non-invasive and posses no risk to the patient. We reasoned that if the study were of high technical quality and demonstrated patent renal arteries, we could avoid contrast administration. Also, given the association of decreasing renal size with progression of renal artery stenosis, we were interested in reassessing the current size of this patient's kidneys [15, 18] .
Dr. Leslie Scoutt from the Diagnostic Imaging Department will address the use and limitations of doppler ultrasound for diagnosing RAS and review the findings in this patient.
Dr Leslie Scoutt:
As discussed by Dr. Huot, angiography remains the radiographic gold standard for the diagnosis of RAS. However, as also discussed, angiography is a suboptimal screening modality, is expensive, invasive, potentially nephrotoxic, and there is risk of atheroemblism.
Doppler ultrasound, a safe, noninvasive, and relatively inexpensive technique, provides both physiologic and anatomic data and has been explored since the 1980s as a method of screening patients for RAS. Most ultrasound studies consider that an obstructing lesion must reduce the arterial diameter by > 60 percent to be hemodynamically significant and diagnostic of RAS. There are two techniques for diagnosing RAS by Doppler ultrasound, both or which were applied to the patient we are discussing.
The first technique requires visualization of the entire main renal artery to search for a focal area of increased peak systolic velocity (PSV) and post-stenotic turbulence at the anatomic site of a stenosis. The second technique requires demonstration of a decrease in the rate of systolic acceleration within parenchymal renal arteries distal to a stenosis.
PSV increases focally at the anatomic site of a hemodynamically significant stenosis. Most authors consider a PSV > 180 cm/sec to be highly suggestive of RAS [19, 20] . As noted above, to diagnose RAS by this ultrasound technique, post-stenotic turbulence should be present as well. Because PSV can vary with cardiac output, the ratio of peak systolic velocity of the main renal artery is compared to peak systolic velocity of the abdominal aorta (renal-aortic ratio: RAR). Studies However, there are many limitations to this technique. The examination is technically difficult, requiring a great deal of expertise with examination times of up to 1-2 h. Even in expert hands, visualization of the entire main renal artery may be impossible in 30-40 percent of patients due to obesity, overlying bowel gas, and aortic calcifications. In addition, the course of the renal arteries is generally tortuous such that the angle of insonation is often suboptimal (> 60 percent) leading to overestimation of velocity. The deep location of the renal arteries, transmitted cardiac/aortic pulsations, as well as respiratory variation may make Doppler sampling difficult. Furthermore, accessory renal arteries, which may occur in 14-24 percent of patients, are rarely detected by color or pulse Doppler examination [24] . Nor would it be likely that stenoses in smaller branch vessels could be detected by this technique. In addition, inadvertent sampling of collateral vessels have also resulted in false-negative examinations in patients with renal artery occlusions [21] [22] [23] .
The second Doppler ultrasound technique for diagnosing RAS involves measuring the rate of systolic acceleration in renal parenchymal arteries which has been reported to decrease distal to a hemodynamically significant stenosis. In fact, the decrease in systolic acceleration becomes more pronounced as blood proceeds distal to the stenosis [25, 26] . Hence a.
-I systolic acceleration and attenuate potential tardus parvus effects (see below) caused by an upstream stenosis [25, 26] .
The rate of systolic acceleration may be evaluated by calculating the acceleration index, acceleration time, or by visual analysis of the renal artery waveform. Stavros et al. [27] defined the acceleration index (Al) as the slope of the line from the onset of systole to the early systolic peak complex (ESP) in meters per second squared and the acceleration time (AT) as the time in seconds from the onset of systole to the ESP (Figure 3a) . In their study, an AI < 3.0 m/s2 was 85 percent accurate, 89 percent sensitive, and 83 percent specific for diagnosing RAS (> 60 percent diameter reduction). An AT >0.07 seconds had an accuracy of 89 percent, sensitivity of 78 percent, and a specificity of 94 percent. An abnormal waveform, defined as loss of the ESP or rounding/flattening of the systolic peak, the so-called tardus parvus waveform, (Figure 3b ) was even more reliable with an accuracy of 96 percent, a sensitivity of 95 percent, and a specificity of 97 percent (Figure 4 ). This technique can be used to monitor the results of percutaneous transluminal angioplasty as well as surgical revascularization as the renal waveform should normalize following a successful procedure (Figure 4) . Rene et al. [28] have reported that premedication with captopril makes this test more sensitive. Schwerk et al. [29] have also demonstrated that the RI of intraparenchymal renal arteries will decrease in patients with moderate to severe RAS.
While this Doppler technique can be adequately performed in almost all patients, some theoretical issues remain unresolved. The technique is more sensitive for diagnosing severe rather than moderate RAS [27, 28] . Lesions within branch vessels or accessory renal arteries may still be missed, although sampling in multiple areas within the kidney (upper, middle and lower poles) will reduce this possibility. Nonetheless, collateral blood flow around a high grade stenosis or occlusion may still obscure the diagnosis of RAS [20] and afterload reducers or myocardial contractility agents might affect systolic acceleration as well. Furthermore, arterial compliance decreases with age, hypertension, and diabetes. A decrease in arterial compliance will increase pulsatility (i.e., the rate of systolic acceleration) and attenuate any tardus parvus effect derived from an upstream stenosis. Such numerous, independent, criteria may explain why all authors have not found this technique to be equally as accurate in all populations [30] . To review this patient's findings:
In January 1995 a renal ultrasound without Doppler examination demonstrated that the right kidney measured 10.1 cm and the left kidney 12.6 cm. The 1.5 cm difference in renal size is a borderline finding suggestive of RAS on the right. A follow-up ultrasound with Doppler examination in August 1995 revealed that the right kidney measured 10.0 cm, while the left kidney measured only 10.9 cm. The apparent decrease in size over 9 months is suggestive of renal vascular disease.
Doppler ultrasound examination of this patient was inconclusive by either of the two techniques I have discussed. The left main renal artery could not be identified due to overlying bowel gas and there was some movement artifact due to her Parkinson's disease. No flow was seen in the right renal artery, but the ultrasonographer could not definitively discern if this was a real finding or a technical problem. Analysis of renal parenchymal waveforms was also inconclusive. Mild flattening of the systolic peak was noted bilaterally, more prominent on the right. However, these findings were not reproducible as the patient had trouble holding her breath and the waveform in the aorta also looked minimally abnormal. The RI's (resistive indices) for both kidneys were 1.0 which is not consistent with RAS (the RI is reported to be low or asymmetric in RAS) [29] . While this ultrasound examination was not diagnostic of RAS, several features were suggestive of RAS which could not be excluded on the basis of these findings. Given the high clinical suspicion of disease and loss of renal length we felt that RAS was still high on the differential diagnosis for this patient and it was decided that another imaging modality would be required.
The ultrasound studies in this patient demonstrate several of the pitfalls of this technique as previously described; the examination is technically difficult, and physical characters such as obesity, or as in this case, the inability to suspend respiration may make it impossible to obtain adequate Doppler tracings from the main renal arteries. Although not a discrete criterion, sonographers rely on the presence of asymmetry in Doppler tracings (PSV, RI, and appearance of waveforms) as a diagnostic clue. Obviously, when disease is bilateral one loses this ability. Furthermore, many systemic factors affect the rate of acceleration in the parenchymal renal arteries. In this case, decreased compliance due to age, atherosclerosis and long standing hypertension with increased peripheral vascular resistance, plus intrinsic medical renal disease (suggested by the abnormal RI of 1.0) might have contributed to blunting of the decrease in systolic acceleration or tardus parvus effect that one looks for with upstream bilateral stenoses.
Dr. Huot:
Given the clinical course, CRS, and ultrasound findings, we thought it possible that this patient had occlusion of the right renal artery and severe stenosis of the left renal artery. We therefore proceeded with an imaging modality that would provide adequate anatomic information upon which to base a decision for revascularization. We [31] .
A second common technique for imaging the vessels in CT angiography is the maximum intensity projection. In this technique, a composite "look-through" image is reconstructed. This image can be rotated in 3600 and is particularly helpful when calcium in atherosclerotic plaque obscures luminal detail. In direct comparison using renal CT angiography, maximum intensity projections seem to be more sensitive at detecting stenoses than does shaded surface display [31] .
The use of iodinated contrast medium is a requisite for conventional X-ray imaging of blood flow. Nevertheless, its use in the absence of arterial catheterization avoids potential atheroembolism as a complicating factor. This remains the fundamental advantage of CT angiography: the lack of intra-arterial catheterization not only prevents catheterinduced atheroembolism, it also allows the study to be virtually pain-free. The imaging requires only a few minutes for data-set capture, after which the analysis is performed on a post-processing workstation. Additionally, with three dimensional luminal reconstruction from the CT data set, anatomic details can be carefully defined and the area of stenosis can be evaluated fully.
In When confronted with new onset renal insufficiency in a patient with diffuse atherosclerotic disease, the challenges of operation are to minimize patient morbidity while providing maximum benefit. In this case, renal salvage was the foremost indication for renal revascularization. Given the risk of atheroembloism associated with angioplasty, particularly in view of the extent of this patient's disease, surgical intervention was chosen.
The common traditional approach to renal revascularization is aortorenal bypass. In this approach, the aorta is clamped, either partially or completely and a graft is placed from the aorta to the renal artery. The main difficulty with this approach is the risk of aortic cross-clamping. When the aorta is cross-clamped, afterload rises precipitously; when the aorta is unclamped, uncompensated hypotension can occur from the rapid afterload reduction, inducing cardiac ischemia. Also, clamping of the aorta can induce atheroembolism in patients such as this with diffuse atherosclerosis. For both reasons we wished to avoid aortic cross-clamping and therefore decided to pursue an "extra-anatomic" bypass procedure.
Extra-anatomic approaches to the renal artery were popularized in the mid-1980s and remain a very attractive alternative for these patients. In this operation, the hepatic or splenic artery is used for an inflow source for a graft to the renal artery. The fundamental advantage in this procedure is avoidance of the hemodynamic and physiologic consequences of aortic cross-clamping. This procedure is limited in patients with atherosclerosis of the celiac axis [32] . In this patient, the celiac axis had minimal disease and appeared appropriate for renal revascularization. Since we were primarily interested in renal functional salvage and not blood pressure control, we decided to revascularize the left kidnay only and avoid the prolonged operative time that would be required to also revascularize the right kidney.
A standard splenorenal bypass was done by direct anastomosis of the splenic artery to the left renal artery ( Figure 5 ). The spleen was not removed. Total operative time was approximately 2 h. Post-operatively, the patient did quite well with an increase in urine flow while still in the operating suite and subsequent improvement in renal function and in blood pressure control. SUMMARY Renal artery stenosis has become increasingly common as a cause of refractory hypertension and renal insufficiency. There is a high prevalence of bilateral disease and the lesions tend to progress over time. Newer, less invasive, imaging modalities such as doppler ultrasound, magnetic resonance angiography, and spiral CT scanning are evolving technologies in the diagnosis of renal artery stenosis. Advances in surgical technique, particularly the development of extra-anatomical procedures such as spleno-renal and hepato-renal bypass, have significantly lowered surgical morbidity and mortality and provides revascularization options for patients with complex vascular disease that would previously not have been considered because of their high surgical risk. Improvements in angioplasty technique and the use of stents are broadening the types of lesions that can be successfully approached with these techniques and may be particularly helpful for patients with more severe cardiac or cerebrovascular disease. The benefits of revascularization may be even greater for preservation of renal function than for control of blood pressure in properly selected patients.
It is difficult to predict which patients will benefit from surgical revascularization versus medical management of RAS. Knowledge of the progressive nature of RAS, the high prevalence of bilateral disease, and the clinical characteristics that correlate with progression (e.g., decreasing renal size) are helpful in guiding clinical decisions regarding intervention. Additional studies to determine the predictive value of non-invasive tests such as CRS, doppler ultrasound before and after administration of angiotensin converting enzyme inhibitors, and other tests, are needed to assist the clinician in identifying who will benefit most from revascularization both in terms of renal function and blood pressure control.
